Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 32Neoplasms 12Prostatic Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Colonic Neoplasms 9Motor Activity 8Lung Neoplasms 8Endometrial Neoplasms 8Colorectal Neoplasms 8Uterine Cervical Neoplasms 7Rectal Neoplasms 7Obesity 7Tobacco Use Disorder 6Small Cell Lung Carcinoma 6Overweight 6Pancreatic Neoplasms 5Leukemia, Myeloid, Acute 5Breast Carcinoma In Situ 5Urinary Bladder Neoplasms 4Ovarian Neoplasms 4Leukemia 4Head and Neck Neoplasms 4Depression 4Carcinoma, Renal Cell 4Carcinoma, Intraductal, Noninfiltrating 4Stomach Neoplasms 3Sexuality 3Sexual Dysfunction, Physiological 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Oropharyngeal Neoplasms 3

Interventions

Venlafaxine Hydrochloride 1Specimen Handling 1Psilocybin 1Interviews as Topic 1Dignity Therapy 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Depressive Disorder × Counseling × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡